TruScreen Group Limited, together with its subsidiaries, develops, manufacture, and sale of cancer detection devices and systems in Mexico, China, Russia, Vietnam, Zimbabwe, Eastern Europe, the Middle East/North Africa, and internationally. The company offers the TruScreen cervical cancer screening device, a medical device for identifying and detecting the presence of precancerous and cancerous tissue on the cervix in real time. The company was formerly known as TruScreen Limited and changed its name to Truscreen Group Limited in August 2020. TruScreen Group Limited was incorporated in 2013 and is headquartered in Auckland, New Zealand.
तुलना करने के लिए मीट्रिक्स | TRU | क्षेत्र सेक्टर - संबंधित क्षेत्र की कंपनियों के व्यापक समूह से मेट्रिक्स का औसत हेल्थकेयर | संबंध संबंधTRUपीअर्सक्षेत्र | |
---|---|---|---|---|
पी/ई अनुपात | −9.4x | 24.0x | −0.5x | |
PEG अनुपात | −0.23 | 0.05 | 0.00 | |
क़ीमत/बुक | 8.3x | 1.9x | 2.6x | |
क़ीमत / एलटीएम बिक्री | 6.4x | 2.4x | 3.0x | |
अपसाइड (विश्लेषक लक्ष्य) | - | 35.3% | 57.3% | |
उचित मूल्य अपसाइड | अनलॉक करें | 8.4% | 10.5% | अनलॉक करें |